162. 類天疱瘡（後天性表皮水疱症を含む。） Pemphigoid Clinical trials / Disease details
臨床試験数 : 90 / 薬物数 : 122 - (DrugBank : 47) / 標的遺伝子数 : 34 - 標的パスウェイ数 : 144
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04117932 (ClinicalTrials.gov) | March 11, 2020 | 4/10/2019 | Efficacy and Safety of Ustekinumab in Bullous Pemphigoid | Efficacy and Safety of Ustekinumab in Bullous Pemphigoid | Bullous Pemphigoid | Drug: Ustekinumab | CHU de Reims | NULL | Recruiting | 18 Years | 90 Years | All | 18 | Phase 2 | France |